Search results
Found 47 matches for
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.
New study finds link between mild COVID-19 disease and certain T cell responses
3 October 2025
The study, led by researchers at the MRC Translational Immune Discovery Unit and the CAMS Oxford Institute (NDM), found that dominant T cell responses found in many individuals 4 years after infection are associated with mild COVID-19 disease, and likely play important protective roles in subsequent viral infection events.
Researchers create first atlas showing cell interactions in lung fibrosis
6 August 2025
New study uncovers key immune cell interaction that could explain failed lung repair in idiopathic pulmonary fibrosis (IPF)
New Study Links Cancer Stage to Strength of Antitumoral Immune Response in HR+ Breast Cancer
29 July 2025
The latest study from Tao Dong's Group in the MRC Translational Immune Discovery Unit has been published in Cell Reports Medicine.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
T cell responses to monkeypox play a part in protecting against infection
15 May 2025
A new study, led by researchers at the MRC TIDU in the MRC Weatherall Institute of Molecular Medicine, NDM's CAMS Oxford Institute, the Centre for Human Genetics, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
Bannard Group receives Wellcome Discovery Award
25 March 2025
Professor Oliver Bannard has been awarded funding for an 8-year research programme investigating how our immune systems establish antibody-mediated immunity following vaccination and during infection.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
21 February 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
Novel pairing of integrins improves action of T cells on cancer cells to control tumour growth
3 April 2024
New research published in Nature Immunology showcases the collaborative efforts of MRC TIDU researchers to describe a novel pairing of integrins which could improve T cell control of cancer.
MRC TIDU Spotlight Series: Dong Group
29 November 2023
In the sixth instalment of the MRC TIDU Spotlight Series, we're taking a look at Tao Dong's Group.
MRC TIDU Spotlight Series: Ho Group
27 October 2023
In the next instalment of the MRC TIDU Spotlight Series, we are focusing on the Ho Group.
Tao Dong appointed the Brigitte (Ita) Askonas Professor of Translational Immunology
20 July 2023
With effect from 1st May 2023, Professor Tao Dong, has been appointed the Brigitte (Ita) Askonas Professor of Translational Immunology.
New UK research consortium formed to tackle monkeypox outbreak
24 October 2022
Investigation of the T cell responses against monkeypox virus will be led by Prof. Tao Dong at the CAMS-Oxford Institute and MRC Human Immunology Unit.
Ziqi Long receives NDM Prize
3 October 2022
DPhil student Ziqi Long has been commended in the category NDM Overall Prize at the annual Nuffield Department of Medicine (NDM) Awards
Learn about cutting-edge research at Oxford Open Doors 2022
5 September 2022
On Saturday 10th September 2022 12.30-4 pm, the MRC WIMM will be joining colleagues from the Medical Sciences Division at the Old Road Campus Research Building (ORCRB) as part of the Oxford Open Doors programme. This event is open to everyone.